Denise Rezende: What Should Clinicians Do When Thrombosis Occurs Despite DOAC Therapy?
Denise Rezende, Product Manager of Systems Worldwide Marketing, Hemostasis at Werfen North America, shared a post on LinkedIn:
”Great topic and a very relevant discussion!
What should clinicians do when thrombosis occurs despite DOAC therapy?
Looking forward to hearing the perspectives of international experts and learning more about the clinical management and different approaches to these challenging situations.
Another great educational initiative supported by Werfen.”
Werfen shared a post on LinkedIn:
”What should clinicians do when thrombosis occurs despite DOAC therapy?
Join the upcoming ISTH webinar, ‘Breakthrough Thrombosis in DOACs: What to do Next,’ where international experts will explore the latest perspectives on managing these challenging cases.
August 19, 2026 | 12:00 PM UTC
Werfen is proud to support educational initiatives that advance understanding in thrombosis and hemostasis.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments